Skip to main content


Professor Emiliangelo Ratti, head of Neuroscience Therapeutic Area for the Takeda Corporation worldwide.

Cardiff University has formed a partnership with Takeda Pharmaceutical Company Limited (Takeda) for a drug discovery collaboration to identify new approaches for treating schizophrenia and other psychiatric disorders.

The collaboration will combine the University's large scale genomic data and world-class expertise in psychiatric genetics, genomics, clinical and basic neuroscience with Takeda’s extensive drug discovery and clinical development capabilities.

The collaboration will allow Takeda access to world-leading biological psychiatry research and the related infrastructure across the University, including the


For more information regarding the Takeda partnership, please contact:

Professor Lawrence Wilkinson

Professor Lawrence Wilkinson

Co Director, Neuroscience and Mental Health Innovation Institute

+44(0) 29 2068 8461